Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Mannhalter

Showing results (141-150 of 184) with videos related to

Pageof 19
Sort By:
British Journal of Haematology|July 11, 2000
Monitoring of minimal residual disease in patients with MLL-AF6-positive acute myeloid leukaemia by reverse transcriptase polymerase chain reactionG Mitterbauer, C Zimmer, H Pirc-Danoewinata, et al.
Neurology|October 26, 2005
Inclusion body myopathy and Paget disease is linked to a novel mutation in the VCP geneD Haubenberger, R E Bittner, S Rauch-Shorny, et al.
British Journal of Haematology|February 15, 2002
Homozygosity for the C-->T polymorphism at nucleotide 46 in the 5' untranslated region of the factor XII gene protects from development of acute coronary syndromeG Endler, C Mannhalter, H Sunder-Plassmann, et al.
Annals of Hematology|January 6, 1999
Graft-versus-host disease following second syngeneic stem cell transplantation for relapsed chronic myeloid leukemiaE Reiter, H T Greinix, G Mitterbauer, et al.
Leukemia & Lymphoma|November 8, 2001
Prospective monitoring of minimal residual disease in acute myeloid leukemia with inversion(16) by CBFbeta/MYH11 RT-PCR: implications for a monitoring schedule and for treatment decisionsK Laczika, G Mitterbauer, M Mitterbauer, et al.
British Journal of Haematology|September 1, 1999
Quantification of minimal residual disease in patients with BCR-ABL-positive acute lymphoblastic leukaemia using quantitative competitive polymerase chain reactionG Mitterbauer, P Nemeth, S Wacha, et al.
European Journal of Clinical Investigation|November 30, 2005
Haem oxygenase-1 genotype and cardiovascular adverse events in patients with peripheral artery diseaseP Dick, M Schillinger, E Minar, et al.
British Journal of Haematology|May 8, 1999
Homocysteine levels in polycythaemia vera and essential thrombocythaemiaH Gisslinger, F Rodeghiero, M Ruggeri, et al.
Blood|September 15, 1995
Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progressionA Gaiger, T Henn, E Hörth, et al.
Kidney International|June 2, 1998
Major determinants of hyperhomocysteinemia in peritoneal dialysis patientsA Vychytil, M Födinger, G Wölfl, et al.
Pageof 19

Showing results (141-150 of 184) with videos related to

Sort By:
Pageof 19
British Journal of Haematology|July 11, 2000
Monitoring of minimal residual disease in patients with MLL-AF6-positive acute myeloid leukaemia by reverse transcriptase polymerase chain reactionG Mitterbauer, C Zimmer, H Pirc-Danoewinata, et al.
Neurology|October 26, 2005
Inclusion body myopathy and Paget disease is linked to a novel mutation in the VCP geneD Haubenberger, R E Bittner, S Rauch-Shorny, et al.
British Journal of Haematology|February 15, 2002
Homozygosity for the C-->T polymorphism at nucleotide 46 in the 5' untranslated region of the factor XII gene protects from development of acute coronary syndromeG Endler, C Mannhalter, H Sunder-Plassmann, et al.
Annals of Hematology|January 6, 1999
Graft-versus-host disease following second syngeneic stem cell transplantation for relapsed chronic myeloid leukemiaE Reiter, H T Greinix, G Mitterbauer, et al.
Leukemia & Lymphoma|November 8, 2001
Prospective monitoring of minimal residual disease in acute myeloid leukemia with inversion(16) by CBFbeta/MYH11 RT-PCR: implications for a monitoring schedule and for treatment decisionsK Laczika, G Mitterbauer, M Mitterbauer, et al.
British Journal of Haematology|September 1, 1999
Quantification of minimal residual disease in patients with BCR-ABL-positive acute lymphoblastic leukaemia using quantitative competitive polymerase chain reactionG Mitterbauer, P Nemeth, S Wacha, et al.
European Journal of Clinical Investigation|November 30, 2005
Haem oxygenase-1 genotype and cardiovascular adverse events in patients with peripheral artery diseaseP Dick, M Schillinger, E Minar, et al.
British Journal of Haematology|May 8, 1999
Homocysteine levels in polycythaemia vera and essential thrombocythaemiaH Gisslinger, F Rodeghiero, M Ruggeri, et al.
Blood|September 15, 1995
Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progressionA Gaiger, T Henn, E Hörth, et al.
Kidney International|June 2, 1998
Major determinants of hyperhomocysteinemia in peritoneal dialysis patientsA Vychytil, M Födinger, G Wölfl, et al.
Pageof 19